| Product Code: ETC9950661 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary  | 
2 Introduction  | 
2.1 Key Highlights of the Report  | 
2.2 Report Description  | 
2.3 Market Scope & Segmentation  | 
2.4 Research Methodology  | 
2.5 Assumptions  | 
3 United Kingdom (UK) Orexin Receptor Antagonists Market Overview  | 
3.1 United Kingdom (UK) Country Macro Economic Indicators  | 
3.2 United Kingdom (UK) Orexin Receptor Antagonists Market Revenues & Volume, 2021 & 2031F  | 
3.3 United Kingdom (UK) Orexin Receptor Antagonists Market - Industry Life Cycle  | 
3.4 United Kingdom (UK) Orexin Receptor Antagonists Market - Porter's Five Forces  | 
3.5 United Kingdom (UK) Orexin Receptor Antagonists Market Revenues & Volume Share, By Dosage, 2021 & 2031F  | 
3.6 United Kingdom (UK) Orexin Receptor Antagonists Market Revenues & Volume Share, By Drugs, 2021 & 2031F  | 
3.7 United Kingdom (UK) Orexin Receptor Antagonists Market Revenues & Volume Share, By Application, 2021 & 2031F  | 
3.8 United Kingdom (UK) Orexin Receptor Antagonists Market Revenues & Volume Share, By End-Users, 2021 & 2031F  | 
4 United Kingdom (UK) Orexin Receptor Antagonists Market Dynamics  | 
4.1 Impact Analysis  | 
4.2 Market Drivers  | 
4.2.1 Increasing prevalence of sleep disorders in the UK population  | 
4.2.2 Growing awareness about the importance of sleep health and its impact on overall well-being  | 
4.2.3 Rise in research and development activities to introduce innovative orexin receptor antagonists in the market  | 
4.3 Market Restraints  | 
4.3.1 Stringent regulatory requirements for drug approval in the UK  | 
4.3.2 High cost associated with the development and commercialization of orexin receptor antagonists  | 
4.3.3 Limited reimbursement policies for sleep disorder medications in the UK healthcare system  | 
5 United Kingdom (UK) Orexin Receptor Antagonists Market Trends  | 
6 United Kingdom (UK) Orexin Receptor Antagonists Market, By Types  | 
6.1 United Kingdom (UK) Orexin Receptor Antagonists Market, By Dosage  | 
6.1.1 Overview and Analysis  | 
6.1.2 United Kingdom (UK) Orexin Receptor Antagonists Market Revenues & Volume, By Dosage, 2021- 2031F  | 
6.1.3 United Kingdom (UK) Orexin Receptor Antagonists Market Revenues & Volume, By 5mg, 2021- 2031F  | 
6.1.4 United Kingdom (UK) Orexin Receptor Antagonists Market Revenues & Volume, By 10mg, 2021- 2031F  | 
6.1.5 United Kingdom (UK) Orexin Receptor Antagonists Market Revenues & Volume, By 15mg, 2021- 2031F  | 
6.1.6 United Kingdom (UK) Orexin Receptor Antagonists Market Revenues & Volume, By 20mg, 2021- 2031F  | 
6.2 United Kingdom (UK) Orexin Receptor Antagonists Market, By Drugs  | 
6.2.1 Overview and Analysis  | 
6.2.2 United Kingdom (UK) Orexin Receptor Antagonists Market Revenues & Volume, By Suvorexant, 2021- 2031F  | 
6.2.3 United Kingdom (UK) Orexin Receptor Antagonists Market Revenues & Volume, By Lemborexant, 2021- 2031F  | 
6.2.4 United Kingdom (UK) Orexin Receptor Antagonists Market Revenues & Volume, By Others, 2021- 2031F  | 
6.3 United Kingdom (UK) Orexin Receptor Antagonists Market, By Application  | 
6.3.1 Overview and Analysis  | 
6.3.2 United Kingdom (UK) Orexin Receptor Antagonists Market Revenues & Volume, By Insomnia, 2021- 2031F  | 
6.3.3 United Kingdom (UK) Orexin Receptor Antagonists Market Revenues & Volume, By Depression, 2021- 2031F  | 
6.3.4 United Kingdom (UK) Orexin Receptor Antagonists Market Revenues & Volume, By Anxiety, 2021- 2031F  | 
6.3.5 United Kingdom (UK) Orexin Receptor Antagonists Market Revenues & Volume, By Others, 2021- 2031F  | 
6.4 United Kingdom (UK) Orexin Receptor Antagonists Market, By End-Users  | 
6.4.1 Overview and Analysis  | 
6.4.2 United Kingdom (UK) Orexin Receptor Antagonists Market Revenues & Volume, By Hospitals, 2021- 2031F  | 
6.4.3 United Kingdom (UK) Orexin Receptor Antagonists Market Revenues & Volume, By Homecare, 2021- 2031F  | 
6.4.4 United Kingdom (UK) Orexin Receptor Antagonists Market Revenues & Volume, By Speciality Centres, 2021- 2031F  | 
6.4.5 United Kingdom (UK) Orexin Receptor Antagonists Market Revenues & Volume, By Others, 2021- 2031F  | 
7 United Kingdom (UK) Orexin Receptor Antagonists Market Import-Export Trade Statistics  | 
7.1 United Kingdom (UK) Orexin Receptor Antagonists Market Export to Major Countries  | 
7.2 United Kingdom (UK) Orexin Receptor Antagonists Market Imports from Major Countries  | 
8 United Kingdom (UK) Orexin Receptor Antagonists Market Key Performance Indicators  | 
8.1 Patient adherence rate to prescribed orexin receptor antagonists  | 
8.2 Number of clinical trials conducted for new orexin receptor antagonist drugs  | 
8.3 Prescription rate of orexin receptor antagonists by healthcare providers  | 
8.4 Average time taken for regulatory approval of new orexin receptor antagonist drugs  | 
9 United Kingdom (UK) Orexin Receptor Antagonists Market - Opportunity Assessment  | 
9.1 United Kingdom (UK) Orexin Receptor Antagonists Market Opportunity Assessment, By Dosage, 2021 & 2031F  | 
9.2 United Kingdom (UK) Orexin Receptor Antagonists Market Opportunity Assessment, By Drugs, 2021 & 2031F  | 
9.3 United Kingdom (UK) Orexin Receptor Antagonists Market Opportunity Assessment, By Application, 2021 & 2031F  | 
9.4 United Kingdom (UK) Orexin Receptor Antagonists Market Opportunity Assessment, By End-Users, 2021 & 2031F  | 
10 United Kingdom (UK) Orexin Receptor Antagonists Market - Competitive Landscape  | 
10.1 United Kingdom (UK) Orexin Receptor Antagonists Market Revenue Share, By Companies, 2024  | 
10.2 United Kingdom (UK) Orexin Receptor Antagonists Market Competitive Benchmarking, By Operating and Technical Parameters  | 
11 Company Profiles  | 
12 Recommendations  | 
13 Disclaimer  |